Form 8-K - Current report:
SEC Accession No. 0001493152-21-016906
Filing Date
2021-07-15
Accepted
2021-07-15 09:54:06
Documents
26
Period of Report
2021-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30714
2 ex99-1.htm EX-99.1 23000
3 ex99-1_025.jpg GRAPHIC 59255
4 ex99-1_002.jpg GRAPHIC 184171
5 ex99-1_003.jpg GRAPHIC 139543
6 ex99-1_004.jpg GRAPHIC 156584
7 ex99-1_005.jpg GRAPHIC 100216
8 ex99-1_006.jpg GRAPHIC 179373
9 ex99-1_007.jpg GRAPHIC 150626
10 ex99-1_008.jpg GRAPHIC 184992
11 ex99-1_009.jpg GRAPHIC 122433
12 ex99-1_010.jpg GRAPHIC 123905
13 ex99-1_011.jpg GRAPHIC 157231
14 ex99-1_012.jpg GRAPHIC 152661
15 ex99-1_013.jpg GRAPHIC 104050
16 ex99-1_014.jpg GRAPHIC 167030
17 ex99-1_015.jpg GRAPHIC 133748
18 ex99-1_016.jpg GRAPHIC 181749
19 ex99-1_017.jpg GRAPHIC 105452
20 ex99-1_018.jpg GRAPHIC 147197
21 ex99-1_019.jpg GRAPHIC 168623
22 ex99-1_020.jpg GRAPHIC 143730
23 ex99-1_021.jpg GRAPHIC 137582
24 ex99-1_022.jpg GRAPHIC 114617
25 ex99-1_023.jpg GRAPHIC 178337
26 ex99-1_024.jpg GRAPHIC 120344
  Complete submission text file 0001493152-21-016906.txt   4757735
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 211091895
SIC: 2834 Pharmaceutical Preparations